celecoxib has been researched along with salicylates in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bing, RJ; Ingram, M; Miyataka, M; Rich, KA; Yamamoto, T | 1 |
| Brum-Fernandes, AJ; Peters, RR; Ribeiro-do-Valle, RM; Siqueira-Junior, JM | 1 |
| Aizman, E; Kloog, Y; Mor, A | 1 |
| Ch Yiannakopoulou, E | 1 |
| Chen, M; Goodin, S; Li, D; Liu, W; Ma, Y; Ren, X; Sheng, Z; Xu, X; Zhang, K; Zheng, X; Zhou, R | 1 |
| Cho, DY; Choi, DK; Choi, SR; Kim, E; Lee, JY; Park, JY; Yoon, SH | 1 |
1 review(s) available for celecoxib and salicylates
| Article | Year |
|---|---|
Interaction of Salicylates and the Other Nonsteroidal Anti-Inflammatory Agents With Breast Cancer Endocrine Treatment: Systematic Review.
Topics: Androstadienes; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Aspirin; Breast Neoplasms; Celecoxib; Drug Synergism; Female; Humans; Salicylates; Tamoxifen | 2015 |
5 other study(ies) available for celecoxib and salicylates
| Article | Year |
|---|---|
Nitric oxide, anti-inflammatory drugs on renal prostaglandins and cyclooxygenase-2.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Isoenzymes; Kidney; Male; Nitrates; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrobenzenes; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Prostaglandins F; Pyrazoles; Rabbits; Salicylates; Sulfonamides; Thromboxane B2 | 2002 |
Effects of valeryl salicylate, a COX-1 inhibitor, on models of acute inflammation in mice.
Topics: Acute Disease; Animals; Arachidonic Acid; Carrageenan; Celecoxib; Croton Oil; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Ear, External; Edema; Foot; Indomethacin; Inflammation; Irritants; Isoenzymes; Male; Membrane Proteins; Mice; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Salicylates; Sulfonamides | 2003 |
Celecoxib enhances the anti-inflammatory effects of farnesylthiosalicylic acid on T cells independent of prostaglandin E(2) production.
Topics: Animals; Celecoxib; Cell Adhesion; Cell Line; Cyclooxygenase 2 Inhibitors; Dinoprostone; Drug Synergism; Extracellular Signal-Regulated MAP Kinases; Farnesol; Humans; Interleukin-2; Jurkat Cells; Mice; Mice, Inbred BALB C; Oncogene Protein p21(ras); Phosphorylation; Pyrazoles; Salicylates; Sulfonamides; T-Lymphocytes | 2012 |
Celecoxib combined with salirasib strongly inhibits pancreatic cancer cells in 2D and 3D cultures.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Caspase 3; Celecoxib; Cell Line, Tumor; Cell Proliferation; Cell Survival; Farnesol; Gene Expression Regulation, Neoplastic; Humans; NF-kappa B; Pancreatic Neoplasms; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Salicylates; Signal Transduction | 2020 |
Synthesis and Biological Evaluation of Salicylic Acid Analogues of Celecoxib as a New Class of Selective Cyclooxygenase-1 Inhibitor.
Topics: Catalytic Domain; Celecoxib; Cyclooxygenase 1; Cyclooxygenase Inhibitors; Enzyme Assays; Molecular Docking Simulation; Molecular Structure; Salicylates; Structure-Activity Relationship | 2021 |